The present invention relates to devices and methods that are used to close septal openings. In particular, this invention is directed to devices and methods that are used to close a patent foramen ovale (PFO) in the septum between the left atrium and right atrium.
A PFO, illustrated in
The foramen ovale serves a desired purpose when a fetus is gestating in utero. Since blood is oxygenated through the umbilical chord, and not through the developing lungs, the circulatory system of a heart in a fetus allows the blood to flow through the foramen ovale as a physiologic conduit for right-to-left shunting. After birth, with the establishment of pulmonary circulation, the increased left atrial blood flow and pressure results in functional closure of the foramen ovale. This functional closure is subsequently followed by anatomical closure of the two over-lapping layers of tissue: septum primum 14 and septum secundum 16. However, a PFO has been shown to persist in a number of adults.
The presence of a PFO is generally considered to have no therapeutic consequence in otherwise healthy adults. Paradoxical embolism via a PFO is considered in the diagnosis for patients who have suffered a stroke or transient ischemic attack (TIA) in the presence of a PFO and without another cause of ischemic stroke. While there is currently no definitive proof for a cause-effect relationship, many studies have confirmed a strong association between the presence of a PFO and the risk for paradoxical embolism or stroke. In addition, there is significant evidence that patients with PFO who have had a cerebral vascular event are at increased risk for future, recurrent cerebrovascular events.
Accordingly, patients with an increased future risk are considered for prophylactic medical therapy to reduce the risk of a recurrent embolic event. These patients are commonly treated with oral anticoagulants, which have the potential for adverse side effects, such as hemorrhaging, hematoma, and interactions with a variety of other drugs. The use of these drugs can alter a person's recovery and necessitate adjustments in a person's daily living pattern.
In certain cases, such as when anticoagulation is contraindicated, surgery may be necessary or desirable to close the PFO. The surgery would typically include suturing a PFO closed by attaching septum secundum to septum primum. This sutured attachment can be accomplished with either an interrupted or a continuous stitch and is a common way a surgeon shuts a PFO under direct visualization.
Umbrella devices and a variety of other similar mechanical closure designs, developed initially for percutaneous closure of atrial septal defects (ASDs), have been used in some instances to close PFOs. These devices have the potential to allow patients to avoid the potential side effects often associated with anticoagulation therapies and the risks of invasive surgery. However, umbrella devices and the like that are designed for ASDs are not optimally suited for use as a PFO closure device.
Currently available designs of septal closure devices present drawbacks, including that the implantation procedure is technically complex. Additionally, there are not insignificant complications due to thrombus, fractures of the components, conduction system disturbances, perforations of heart tissue, and residual leaks. Many devices have high septal profile and may include large masses of foreign material, which may lead to unfavorable body adaptation of a device. Since ASD devices are designed to occlude a hole, many lack anatomic conformability to the PFO flap-like anatomy. That is, when inserting an ASD device to close a PFO, the narrow opening and the thin flap may form impediments to proper deployment. Even if an occlusive seal is formed, the device may be deployed in the heart on an angle, which could leave some components not securely seated against the septum. Finally, some septal closure devices are complex to manufacture, which may result in lack of consistency in product performance.
The present invention is designed to address these and other deficiencies of the prior art septal closure devices.
The present invention provides patent foramen ovale (PFO) closure clips. The clips of the present invention include two closure members joined by at least two spaced central connecting members. Each of the at least two spaced central connecting members is attached to each closure member at a location on the periphery of the closure member. The clips are designed such that the at least two central connecting members extend through the inclined PFO tunnel and the two closure members compress the overlapping layers of septal tissue, i.e. septum primum and septum secundum, together to close the PFO tunnel.
The clips of the present invention may be formed of various materials. In at least some embodiments, the clips are formed of metals, nonmetallic materials, bioabsorbable polymers, spring steel, shape memory materials, bioabsorbable shape memory polymers, or combinations thereof.
The clips of the present invention take various forms depending, in part, upon the distribution of force required to close a given PFO. Thus, in some embodiments, the closure members include arcuate peaks. In other embodiments, the closure members include loops. In still other embodiments, the closure members include prongs. In yet other embodiments, the closure members include centering elements.
In at least some embodiments, the clips of the present invention are repositionable and/or retrievable. In some embodiments, at least one of the closure members includes a tissue scaffold.
a and 2b are a front elevational view and a side view, respectively, of a PFO closure clip according to a first embodiment of the present invention;
a and 3b are side elevational views of the PFO closure clip of
a and 5b are front elevational views of a PFO closure clip according to a second embodiment of the present invention as seen from the left and right atria, respectively;
a and 6b are front elevational views of a PFO closure clip according to a third embodiment of the present invention as seen from the left and right atria, respectively;
a and 7b are front elevational views of a PFO closure clip according to a fourth embodiment of the present invention as seen from the left and right atria, respectively;
a and 8b are front elevational views of a PFO closure clip according to a fifth embodiment of the present invention as seen from the left and right atria, respectively;
The clip devices of the present invention are intended to clip septum primum to septum secundum to thereby minimize the flow of blood between the right and left atria. The clip devices assist in reducing the risk of stroke by preventing the passage of embolic particles from the right atrium to the left atrium through a PFO. To accomplish this, the clip devices apply a compressive force to the overlapping layers of septal tissue between the right and left atria, i.e. septum primum and septum secundum. In at least some embodiments, the applied compressive force “pulls” the more flexible septum primum toward septum secundum, thereby closing the PFO without significantly distorting the septum, as occurs with many of the septal closure devices of the prior art. In this application, compressive force is intended to include force sufficient to bring septum primum and septum secundum together to provide a closing effect. In some embodiments, the clip provides mechanical closure at enough points of contact along the PFO that the single largest remaining conduit is reduced to a size deemed small enough to block stroke-inducing embolic particles from crossing through the PFO tunnel. In other embodiments, the clip provides substantially complete closure along the entire PFO length. Because the clip devices of the present invention do not distort the defect, the overlapping layers of septal tissues may themselves be used to close the defect as they are compressed by the clip device. Accordingly, in at least some embodiments, the application of a compressive force to the septal tissues using the clip devices of the present invention may ultimately induce anatomical closure of septum primum and septum secundum (i.e. septum primum and septum secundum will fuse together by natural processes).
The clip devices of the present invention may be formed of metal wire, nonmetallic materials, bioabsorbable polymers, spring steel, shape memory materials (e.g. nitinol), bioabsorbable shape memory polymers, or combinations of the foregoing materials. In some embodiments, the clip devices are formed of a single piece of material, while in other embodiments, the clip devices are formed of multiple pieces of material.
In particular embodiments, the clip devices are formed of shape memory material (e.g. nitinol), which allows the clips to resume and maintain their intended shape following deployment in vivo. A clip according to the present invention may use the thermal shape memory properties of a shape memory material, the superelastic properties of a shape memory material, or some combination of the two. In other particular embodiments, the clip devices are cut into their desired shapes from sheets of material, including bioabsorbable shape memory polymers. Those skilled in the art will recognize that the device could be made of a combination of materials. Those of skill in the art will be able to identify biocompatible clip materials suited for particular applications, and the manufacturing techniques that would be used to configure the material into specific clip designs.
In at least some embodiments, the clip devices of the present invention include first and second closure members connected by at least two spaced central connecting members. Each central connecting member is attached to each closure member at a point on the periphery of the closure member. The central connecting member may be any strand of material, e.g. a wire or portion of wire, that connects the closure members. The connecting members are intended to pass through the PFO tunnel. After deployment into the heart, the second closure member is located in the left atrium and the first closure member is located in the right atrium, such that the central connecting members extend through the PFO tunnel, as described below for the various embodiments of the present invention.
The first and second closure members may be constituted of a material or be configured to apply a compressive force to the overlapping layers of septal tissue. Further, the movement of the at least two spaced central connecting members extending through the PFO tunnel may be limited by the edges of the PFO tunnel (which is usually between 1 mm and 20 mm wide), thereby ensuring the clip device remains horizontally centered across the defect and consistently applies compressive force to the septal tissues at the locations necessary to effect closure of the defect. This accurate and consistent application of localized force permits the use of a smaller closure device.
In some embodiments, the clip devices of the present invention include only one closure member and at least one connecting member. The connecting member passes through the PFO tunnel and secures the closure member in place.
The closure members of the clip devices may take various forms depending, in part, upon the distribution of force desired to effect closure of a given defect. In this application, the term defect is applied to any anatomical configuration requiring treatment. In particular, the defect can be a PFO which may allow, or allows, blood to flow from the right atrium to the left atrium. The shape of each closure member determines the location(s) at which the compressive force is applied to the overlapping layers of septal tissue.
In some embodiments, the compressive force is concentrated at the center of the longitudinal distance of the PFO tunnel. In other embodiments, the compressive force is distributed along the length of the defect. In still other embodiments, the compressive force is applied toward the edges of the PFO defect. Of course, the force may be a combination of the above-described forces. In at least some embodiments, the closure devices of the present invention are low profile devices, i.e. the closure members contact the septal tissue both inferior to and superior to the PFO tunnel entrance in the left atrium or the right atrium or both. The device may include configurations that are centered horizontally or vertically in the PFO. These and other embodiments of the clip devices of the present invention are described below. In the Figures, the directional indications, e.g. downward and upward, are meant to facilitate understanding of the invention and are not intended to limit the invention in any manner.
Referring to
The clip 18 includes a first closure member 22 that overlies a second closure member 24. The first and second closure members 22 and 24 of the clip 18 are biased toward one another and, as shown in
The second closure member 24 is substantially identical in construction to the first closure member 22 but is oriented in a reverse manner to the first closure member 22. The second closure member includes an arcuate peak 40, aligned with but spaced opposite to the arcuate peak 26, that joins two outwardly angled, elongate side strands 42 and 44. At their uppermost extremities, elongate side strands 42 and 44 are looped to provide spaced top loops 46 and 48, respectively, for the second closure member 24, which are substantially aligned with but spaced opposite to bottom loops 32 and 34. Loops 46 and 48 extend into straight, spaced, elongate, connecting strands 36 and 38, respectively. The same configuration adjustments may be made to the second closure member as suggested for the first closure member.
a, 3b, and 4 show the clip 18 in place to close a PFO. Clip 18 may be elongated and deployed through a catheter. The catheter enters the right atrium and is inserted through the PFO tunnel into the left atrium. Closure member 24 is then ejected into the left atrium, where it resumes the shape shown in
Once deployed, clip 18 is centered horizontally across the PFO because the movement of spaced, elongate connecting strands 36 and 38 is limited by the edges of the PFO tunnel. Thus, clip 18 consistently applies pressure to the overlapping layers of septal tissue at the locations where outwardly angled side strands 28 and 42 and 30 and 44 overlap. Lesser pressures are also applied at the locations where peaks 26 and 40 and loops 32, 34, 46, and 48 engage septum primum and septum secundum.
As illustrated, the angle of peak 26, i.e. the angle formed by wires 28 and 30, is slightly larger than 90 degrees. Of course, one skilled in the art will recognize that the “peak angle” could be 180°, which would effectively create a transverse strand across the tissues forming the PFO tunnel. The “peak angles” could be different on one side of the septum than on the other, e.g. the “peak angles” could vary on the closure members in the left and right atria. When determining the “peak angles” for a given clip according to the invention, one design consideration would be the difference in thickness between septum secundum and septum primum. The device should have a design that compresses (or at least holds) septum primum and septum secundum together.
Depending on the anatomy of the septum and the forces applied by the clip, the loops and peaks may contact the septum. Since the septum is generally stiff but not actually rigid, the tissue will generally conform to the forces applied to it. This is particularly true for septum primum. Accordingly, any illustration of the clip as shown schematically in the heart should be considered as exemplary and not limiting.
In at least some embodiments, the closure clip of the present invention is repositionable and/or retrievable. For example, as shown in
The closure clip of the present invention may have a variety of configurations. In one embodiment (
The clip 18c may also be modified to ensure it remains vertically centered after being deployed across the PFO (
The connecting members also serve a horizontal centering function. Specifically, the connecting members may be designed to fit within the PFO tunnel such that there is little (or no) horizontal movement once the device is deployed. Horizontal centering is important because the dynamic conditions in the heart may tend to move the device. Of course, various configurations, including bent or slightly bent wires, to position the connecting members within the PFO tunnel are within the scope of this invention.
In a further embodiment, the movement of clip 18d across the defect is limited by small diameter centering elements 49, which may be of the type disclosed in U.S. Pat. No. 5,709,707, hereby incorporated by reference. The centering elements are attached to and connect closure members 22d and 24d. These centering elements may be springs and may be formed of metal, plastic, elastic materials, or shape memory materials (e.g. nitinol). The connectors are attached to closure members 22d and 24d such that the inherent tendency of the springs to straighten will center the clip 18d across the defect following its deployment. For example, as shown in
While closure members 22 and 24 of the various embodiments of clip 18 have been shown and described in pairs, the present invention is not limited to these illustrated combinations. In fact, a clip device including any of the various embodiments of closure member 22 disclosed herein in combination with any of the various embodiments of closure member 24 disclosed herein may be used to close a PFO and is considered within the scope of the present invention.
Referring now to
Referring now to
The clip 80 may be delivered through a catheter in a straight, elongate form. In at least some embodiments, the clip 80 is constructed from a shape memory material (e.g. nitinol), such that clip 80 resumes the shape shown in
The clip 80 may be modified in various ways. Thus, according to some embodiments (
In still other embodiments, the clip 80 may be modified to encourage the anatomical closure of the overlapping layers of septal tissue by additional means. For example, as shown in
Any of the clip embodiments of the present invention may include a tissue scaffold on one or both closure members. The tissue scaffold promotes encapsulation and endothelialization, thereby further encouraging anatomical closure of septum primum and septum secundum. The tissue scaffold may be formed of any flexible material capable of promoting tissue growth, including but not limited to polyester fabrics, Teflon-based materials, polyurethanes, other natural materials (e.g. collagen), or combinations of the foregoing materials.
The compressive force applied by the closure members of any of the various embodiments described herein may be adjusted in a variety of ways. For example, the thickness of the strand or wire may be increased or decreased to adjust the compressive force. In general (and with other design considerations similar), a thicker strand or wire will provide higher compressive force. Additionally, various closure member configurations may be chosen to increase the compressive force. Generally, bends with smaller angles will provide more compressive force. One skilled in the art will recognize the various design modifications that could be used to adjust the compressive force of the device.
Having described embodiments of the present invention, it should be apparent that the invention is capable of other and different embodiments and may be modified in various respects, all without departing from the scope of the invention as defined by the appended claims. Accordingly, the foregoing drawings and description are to be regarded as illustrative in nature and not in a restrictive or limiting sense.
The instant patent application claims priority to U.S. Provisional Patent Application 60/366,534, filed Mar. 25, 2002, which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
649338 | McGill | May 1900 | A |
2642638 | Larrabee | Jun 1953 | A |
3824631 | Burstein et al. | Jul 1974 | A |
3874388 | King et al. | Apr 1975 | A |
3875648 | Bone | Apr 1975 | A |
3924631 | Mancusi, Jr. | Dec 1975 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4007743 | Blake | Feb 1977 | A |
4149327 | Hammer et al. | Apr 1979 | A |
4425908 | Simon | Jan 1984 | A |
4610674 | Suzuki et al. | Sep 1986 | A |
4626245 | Weinstein | Dec 1986 | A |
4693249 | Schenck et al. | Sep 1987 | A |
4696300 | Anderson | Sep 1987 | A |
4710181 | Fuqua | Dec 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4738666 | Fuqua | Apr 1988 | A |
4836204 | Landymore et al. | Jun 1989 | A |
4840623 | Quackenbush | Jun 1989 | A |
4902508 | Badylak et al. | Feb 1990 | A |
4915107 | Rebuffat et al. | Apr 1990 | A |
4917089 | Sideris | Apr 1990 | A |
4921479 | Grayzel | May 1990 | A |
4956178 | Badylak et al. | Sep 1990 | A |
5021059 | Kensey et al. | Jun 1991 | A |
5037433 | Wilk et al. | Aug 1991 | A |
5041129 | Hayhurst et al. | Aug 1991 | A |
5049131 | Deuss | Sep 1991 | A |
5078736 | Behl | Jan 1992 | A |
5106913 | Yamaguchi et al. | Apr 1992 | A |
5108420 | Marks | Apr 1992 | A |
5149327 | Oshiyama | Sep 1992 | A |
5163131 | Row et al. | Nov 1992 | A |
5167363 | Adkinson et al. | Dec 1992 | A |
5167637 | Okada et al. | Dec 1992 | A |
5171259 | Inoue | Dec 1992 | A |
5176659 | Mancini | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5222974 | Kensey et al. | Jun 1993 | A |
5226879 | Ensminger et al. | Jul 1993 | A |
5236440 | Hlavacek | Aug 1993 | A |
5245023 | Peoples et al. | Sep 1993 | A |
5245080 | Aubard et al. | Sep 1993 | A |
5250430 | Peoples et al. | Oct 1993 | A |
5257637 | El Gazayerli | Nov 1993 | A |
5275826 | Badylak et al. | Jan 1994 | A |
5282827 | Kensey et al. | Feb 1994 | A |
5284488 | Sideris | Feb 1994 | A |
5304184 | Hathaway et al. | Apr 1994 | A |
5312341 | Turi | May 1994 | A |
5312435 | Nash et al. | May 1994 | A |
5316262 | Koebler | May 1994 | A |
5320611 | Bonutti et al. | Jun 1994 | A |
5334217 | Das | Aug 1994 | A |
5350363 | Goode et al. | Sep 1994 | A |
5354308 | Simon et al. | Oct 1994 | A |
5364356 | Hofling | Nov 1994 | A |
5411481 | Allen et al. | May 1995 | A |
5413584 | Schulze | May 1995 | A |
5417699 | Klein et al. | May 1995 | A |
5425744 | Fagan et al. | Jun 1995 | A |
5433727 | Sideris | Jul 1995 | A |
5451235 | Lock et al. | Sep 1995 | A |
5453099 | Lee et al. | Sep 1995 | A |
5478353 | Yoon | Dec 1995 | A |
5480353 | Garza, Jr. | Jan 1996 | A |
5480424 | Cox | Jan 1996 | A |
5486193 | Bourne et al. | Jan 1996 | A |
5507811 | Koike et al. | Apr 1996 | A |
5534432 | Peoples et al. | Jul 1996 | A |
5540712 | Kleshinski et al. | Jul 1996 | A |
5562632 | Davila et al. | Oct 1996 | A |
5577299 | Thompson et al. | Nov 1996 | A |
5601571 | Moss | Feb 1997 | A |
5603703 | Elsberry et al. | Feb 1997 | A |
5618311 | Gryskiewicz | Apr 1997 | A |
5620461 | Muijs Van De Moer et al. | Apr 1997 | A |
5626599 | Bourne et al. | May 1997 | A |
5634936 | Linden et al. | Jun 1997 | A |
5649950 | Bourne et al. | Jul 1997 | A |
5649959 | Hannam et al. | Jul 1997 | A |
5663063 | Peoples et al. | Sep 1997 | A |
5683411 | Kavteladze et al. | Nov 1997 | A |
5690674 | Diaz | Nov 1997 | A |
5693085 | Buirge et al. | Dec 1997 | A |
5702421 | Schneidt | Dec 1997 | A |
5709707 | Lock et al. | Jan 1998 | A |
5713864 | Verkaart | Feb 1998 | A |
5717259 | Schexnayder | Feb 1998 | A |
5720754 | Middleman et al. | Feb 1998 | A |
5725552 | Kotula et al. | Mar 1998 | A |
5733294 | Forber et al. | Mar 1998 | A |
5733337 | Carr, Jr. et al. | Mar 1998 | A |
5741297 | Simon | Apr 1998 | A |
5772641 | Wilson | Jun 1998 | A |
5776162 | Kleshinski | Jul 1998 | A |
5776183 | Kanesaka et al. | Jul 1998 | A |
5797960 | Stevens et al. | Aug 1998 | A |
5800516 | Fine et al. | Sep 1998 | A |
5810884 | Kim | Sep 1998 | A |
5820594 | Fontirroche et al. | Oct 1998 | A |
5823956 | Roth et al. | Oct 1998 | A |
5829447 | Stevens et al. | Nov 1998 | A |
5853420 | Chevillon et al. | Dec 1998 | A |
5853422 | Huebsch et al. | Dec 1998 | A |
5855614 | Stevens et al. | Jan 1999 | A |
5861003 | Latson et al. | Jan 1999 | A |
5865791 | Whayne et al. | Feb 1999 | A |
5879366 | Shaw et al. | Mar 1999 | A |
5893856 | Jacob et al. | Apr 1999 | A |
5902287 | Martin | May 1999 | A |
5902319 | Daley | May 1999 | A |
5904703 | Gilson | May 1999 | A |
5919200 | Stambaugh et al. | Jul 1999 | A |
5924424 | Stevens et al. | Jul 1999 | A |
5928250 | Koike et al. | Jul 1999 | A |
5944691 | Querns et al. | Aug 1999 | A |
5944738 | Amplatz et al. | Aug 1999 | A |
5955110 | Patel et al. | Sep 1999 | A |
5976174 | Ruiz | Nov 1999 | A |
5980505 | Wilson | Nov 1999 | A |
5989268 | Pugsley, Jr. et al. | Nov 1999 | A |
5993475 | Lin et al. | Nov 1999 | A |
5993844 | Abraham et al. | Nov 1999 | A |
5997575 | Whitson et al. | Dec 1999 | A |
6010517 | Baccaro | Jan 2000 | A |
6015417 | Reynolds, Jr. | Jan 2000 | A |
6019753 | Pagan | Feb 2000 | A |
6024756 | Huebsch et al. | Feb 2000 | A |
6027519 | Stanford | Feb 2000 | A |
6030007 | Bassily et al. | Feb 2000 | A |
6056760 | Koike et al. | May 2000 | A |
6071998 | Muller et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6077291 | Das | Jun 2000 | A |
6077880 | Castillo et al. | Jun 2000 | A |
6079414 | Roth | Jun 2000 | A |
6080182 | Shaw et al. | Jun 2000 | A |
6096347 | Geddes et al. | Aug 2000 | A |
6106913 | Scardino et al. | Aug 2000 | A |
6113609 | Adams | Sep 2000 | A |
6117159 | Huebsch et al. | Sep 2000 | A |
6126686 | Badylak et al. | Oct 2000 | A |
6132438 | Fleischman et al. | Oct 2000 | A |
6143037 | Goldstein et al. | Nov 2000 | A |
6152144 | Lesh et al. | Nov 2000 | A |
6165183 | Kuehn et al. | Dec 2000 | A |
6165204 | Levinson et al. | Dec 2000 | A |
6168588 | Wilson | Jan 2001 | B1 |
6171320 | Monassevitch | Jan 2001 | B1 |
6171329 | Shaw et al. | Jan 2001 | B1 |
6174322 | Schneidt | Jan 2001 | B1 |
6174330 | Stinson | Jan 2001 | B1 |
6183443 | Kratoska et al. | Feb 2001 | B1 |
6187039 | Hiles et al. | Feb 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6190357 | Ferrari et al. | Feb 2001 | B1 |
6197016 | Fourkas et al. | Mar 2001 | B1 |
6199262 | Martin | Mar 2001 | B1 |
6206895 | Levinson | Mar 2001 | B1 |
6206907 | Marino et al. | Mar 2001 | B1 |
6214029 | Thill et al. | Apr 2001 | B1 |
6217590 | Levinson | Apr 2001 | B1 |
6221092 | Koike et al. | Apr 2001 | B1 |
6227139 | Nguyen et al. | May 2001 | B1 |
6228097 | Levinson et al. | May 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6245080 | Levinson | Jun 2001 | B1 |
6245537 | Williams et al. | Jun 2001 | B1 |
6261309 | Urbanski | Jul 2001 | B1 |
6265333 | Dzenis et al. | Jul 2001 | B1 |
6270515 | Linden et al. | Aug 2001 | B1 |
6277138 | Levinson et al. | Aug 2001 | B1 |
6277139 | Levinson et al. | Aug 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6290674 | Roue et al. | Sep 2001 | B1 |
6299635 | Frantzen | Oct 2001 | B1 |
6306150 | Levinson | Oct 2001 | B1 |
6306424 | Vyakarnam et al. | Oct 2001 | B1 |
6312443 | Stone | Nov 2001 | B1 |
6312446 | Huebsch et al. | Nov 2001 | B1 |
6315791 | Gingras et al. | Nov 2001 | B1 |
6316262 | Huisman et al. | Nov 2001 | B1 |
6319263 | Levinson | Nov 2001 | B1 |
6322548 | Payne et al. | Nov 2001 | B1 |
6328727 | Frazier et al. | Dec 2001 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6342064 | Koike et al. | Jan 2002 | B1 |
6344048 | Chin et al. | Feb 2002 | B1 |
6344049 | Levinson et al. | Feb 2002 | B1 |
6346074 | Roth | Feb 2002 | B1 |
6348041 | Klint | Feb 2002 | B1 |
6352552 | Levinson et al. | Mar 2002 | B1 |
6355052 | Neuss et al. | Mar 2002 | B1 |
6356782 | Sirimanne et al. | Mar 2002 | B1 |
6358238 | Sherry | Mar 2002 | B1 |
6364853 | French et al. | Apr 2002 | B1 |
6371904 | Sirimanne et al. | Apr 2002 | B1 |
6375625 | French et al. | Apr 2002 | B1 |
6375671 | Kobayashi et al. | Apr 2002 | B1 |
6379342 | Levinson | Apr 2002 | B1 |
6379368 | Corcoran et al. | Apr 2002 | B1 |
6387104 | Pugsley, Jr. et al. | May 2002 | B1 |
6398796 | Levinson | Jun 2002 | B2 |
6402772 | Amplatz et al. | Jun 2002 | B1 |
6419669 | Frazier et al. | Jul 2002 | B1 |
6426145 | Moroni | Jul 2002 | B1 |
6436088 | Frazier et al. | Aug 2002 | B2 |
6440152 | Gainor et al. | Aug 2002 | B1 |
6450987 | Kramer | Sep 2002 | B1 |
6460749 | Levinson et al. | Oct 2002 | B1 |
6482224 | Michler et al. | Nov 2002 | B1 |
6488706 | Solymar | Dec 2002 | B1 |
6494846 | Margolis | Dec 2002 | B1 |
6494888 | Laufer et al. | Dec 2002 | B1 |
6508828 | Akerfeldt et al. | Jan 2003 | B1 |
6514515 | Williams | Feb 2003 | B1 |
6537286 | Acampora et al. | Mar 2003 | B2 |
6548569 | Williams et al. | Apr 2003 | B1 |
6551303 | Van Tassel et al. | Apr 2003 | B1 |
6551344 | Thill | Apr 2003 | B2 |
6585719 | Wang | Jul 2003 | B2 |
6585755 | Jackson et al. | Jul 2003 | B2 |
6596013 | Yang et al. | Jul 2003 | B2 |
6599448 | Ehrhard, Jr. et al. | Jul 2003 | B1 |
6610764 | Martin et al. | Aug 2003 | B1 |
6623508 | Shaw et al. | Sep 2003 | B2 |
6623518 | Thompson et al. | Sep 2003 | B2 |
6626936 | Stinson | Sep 2003 | B2 |
6629901 | Huang | Oct 2003 | B2 |
6666861 | Grabek | Dec 2003 | B1 |
6669722 | Chen et al. | Dec 2003 | B2 |
6689589 | Huisman et al. | Feb 2004 | B2 |
6712804 | Roue et al. | Mar 2004 | B2 |
6712836 | Berg et al. | Mar 2004 | B1 |
6726696 | Houser et al. | Apr 2004 | B1 |
6828357 | Martin et al. | Dec 2004 | B1 |
6838493 | Williams et al. | Jan 2005 | B2 |
6867247 | Williams et al. | Mar 2005 | B2 |
6867248 | Martin et al. | Mar 2005 | B1 |
6867249 | Lee et al. | Mar 2005 | B2 |
6911037 | Gainor et al. | Jun 2005 | B2 |
6921410 | Porter | Jul 2005 | B2 |
7097653 | Freudenthal et al. | Aug 2006 | B2 |
20010010481 | Blanc et al. | Aug 2001 | A1 |
20010014800 | Frazier et al. | Aug 2001 | A1 |
20010025132 | Alferness et al. | Sep 2001 | A1 |
20010034537 | Shaw et al. | Oct 2001 | A1 |
20010034567 | Allen et al. | Oct 2001 | A1 |
20010037129 | Thill | Nov 2001 | A1 |
20010039435 | Roue et al. | Nov 2001 | A1 |
20010039436 | Frazier et al. | Nov 2001 | A1 |
20010041914 | Frazier et al. | Nov 2001 | A1 |
20010041915 | Roue et al. | Nov 2001 | A1 |
20010044639 | Levinson | Nov 2001 | A1 |
20010049492 | Frazier et al. | Dec 2001 | A1 |
20020010481 | Jayaraman | Jan 2002 | A1 |
20020019648 | Akerfeldt et al. | Feb 2002 | A1 |
20020022859 | Hogendijk | Feb 2002 | A1 |
20020022860 | Borillo et al. | Feb 2002 | A1 |
20020026208 | Roe et al. | Feb 2002 | A1 |
20020029048 | Miller | Mar 2002 | A1 |
20020032459 | Horzewski et al. | Mar 2002 | A1 |
20020032462 | Houser et al. | Mar 2002 | A1 |
20020034259 | Tada | Mar 2002 | A1 |
20020035374 | Borillo et al. | Mar 2002 | A1 |
20020043307 | Ishida et al. | Apr 2002 | A1 |
20020049457 | Kaplan et al. | Apr 2002 | A1 |
20020052572 | Franco et al. | May 2002 | A1 |
20020058989 | Chen et al. | May 2002 | A1 |
20020077555 | Schwartz | Jun 2002 | A1 |
20020095174 | Tsugita et al. | Jul 2002 | A1 |
20020096183 | Stevens et al. | Jul 2002 | A1 |
20020099389 | Michler et al. | Jul 2002 | A1 |
20020099390 | Kaplan et al. | Jul 2002 | A1 |
20020103492 | Kaplan et al. | Aug 2002 | A1 |
20020107531 | Schreck et al. | Aug 2002 | A1 |
20020111537 | Taylor et al. | Aug 2002 | A1 |
20020111637 | Kaplan et al. | Aug 2002 | A1 |
20020111647 | Khairkhahan et al. | Aug 2002 | A1 |
20020120323 | Thompson et al. | Aug 2002 | A1 |
20020128680 | Pavlovic | Sep 2002 | A1 |
20020129819 | Feldman et al. | Sep 2002 | A1 |
20020164729 | Skraly et al. | Nov 2002 | A1 |
20020169377 | Khairkhahan et al. | Nov 2002 | A1 |
20020183786 | Girton | Dec 2002 | A1 |
20020183787 | Wahr et al. | Dec 2002 | A1 |
20020183823 | Pappu | Dec 2002 | A1 |
20020198563 | Gainor et al. | Dec 2002 | A1 |
20030004533 | Dieck et al. | Jan 2003 | A1 |
20030023266 | Welch et al. | Jan 2003 | A1 |
20030028213 | Thill et al. | Feb 2003 | A1 |
20030045893 | Ginn | Mar 2003 | A1 |
20030050665 | Ginn | Mar 2003 | A1 |
20030055455 | Yang et al. | Mar 2003 | A1 |
20030057156 | Peterson et al. | Mar 2003 | A1 |
20030059640 | Marton et al. | Mar 2003 | A1 |
20030065379 | Babbas et al. | Apr 2003 | A1 |
20030100920 | Akin et al. | May 2003 | A1 |
20030120337 | Van Tassel et al. | Jun 2003 | A1 |
20030139819 | Beer et al. | Jul 2003 | A1 |
20030171774 | Freudenthal et al. | Sep 2003 | A1 |
20030191495 | Ryan et al. | Oct 2003 | A1 |
20030195530 | Thill | Oct 2003 | A1 |
20030204203 | Khairkhahan et al. | Oct 2003 | A1 |
20040044361 | Frazier et al. | Mar 2004 | A1 |
20040073242 | Chanduszko | Apr 2004 | A1 |
20040176799 | Chanduszko et al. | Sep 2004 | A1 |
20040210301 | Obermiller | Oct 2004 | A1 |
20040234567 | Dawson | Nov 2004 | A1 |
20050025809 | Hasirci et al. | Feb 2005 | A1 |
20050043759 | Chanduszko | Feb 2005 | A1 |
20050113868 | Devellian et al. | May 2005 | A1 |
20050267523 | Devellian et al. | Dec 2005 | A1 |
20050273135 | Chanduszko et al. | Dec 2005 | A1 |
20050288786 | Chanduszko | Dec 2005 | A1 |
20060122647 | Callaghan et al. | Jun 2006 | A1 |
20060265004 | Callaghan et al. | Nov 2006 | A1 |
20070010851 | Chanduszko et al. | Jan 2007 | A1 |
20070167981 | Opolski | Jul 2007 | A1 |
Number | Date | Country |
---|---|---|
9413645 | Oct 1994 | DE |
196 04 817 | Aug 1997 | DE |
0362113 | Apr 1990 | EP |
0474887 | Mar 1992 | EP |
0839549 | May 1998 | EP |
0 861 632 | Sep 1998 | EP |
1 013 227 | Jun 2000 | EP |
1 046 375 | Oct 2000 | EP |
1 222 897 | Jul 2002 | EP |
WO 9625179 | Aug 1996 | WO |
WO 9631157 | Oct 1996 | WO |
WO-9807375 | Feb 1998 | WO |
WO-9808462 | Mar 1998 | WO |
WO-9816174 | Apr 1998 | WO |
WO-9829026 | Jul 1998 | WO |
WO-9851812 | Nov 1998 | WO |
WO-9905977 | Feb 1999 | WO |
WO-9818864 | Apr 1999 | WO |
WO-9918862 | Apr 1999 | WO |
WO-9918864 | Apr 1999 | WO |
WO-9918870 | Apr 1999 | WO |
WO-9918871 | Apr 1999 | WO |
WO-9930640 | Jun 1999 | WO |
WO-9939646 | Aug 1999 | WO |
WO 0027292 | May 2000 | WO |
WO 0044428 | Aug 2000 | WO |
WO-0108600 | Feb 2001 | WO |
WO-0119256 | Mar 2001 | WO |
WO-0121247 | Mar 2001 | WO |
WO-0128432 | Apr 2001 | WO |
WO-0130268 | May 2001 | WO |
WO 0149185 | Jul 2001 | WO |
WO-0178596 | Oct 2001 | WO |
WO-0193783 | Dec 2001 | WO |
WO-0217809 | Mar 2002 | WO |
WO 0224106 | Mar 2002 | WO |
WO-03024337 | Mar 2003 | WO |
WO-03053493 | Jul 2003 | WO |
WO-0353493 | Jul 2003 | WO |
WO-03059152 | Jul 2003 | WO |
WO 03077733 | Sep 2003 | WO |
WO-03082076 | Oct 2003 | WO |
WO-03103476 | Dec 2003 | WO |
WO-03103476 | Dec 2003 | WO |
WO-2004032993 | Apr 2004 | WO |
WO-2004037333 | May 2004 | WO |
WO-2004043266 | May 2004 | WO |
WO-2004043508 | May 2004 | WO |
WO-2004052213 | Jun 2004 | WO |
WO-2005006990 | Jan 2005 | WO |
WO-2005018728 | Mar 2005 | WO |
WO-2005027752 | Mar 2005 | WO |
WO-2005074813 | Aug 2005 | WO |
WO-2005092203 | Oct 2005 | WO |
WO-2005110240 | Nov 2005 | WO |
WO-2005112779 | Dec 2005 | WO |
WO-2006036837 | Apr 2006 | WO |
WO-2006102213 | Sep 2006 | WO |
Entry |
---|
Stöckel, “Nitinol Medical Devices and Implants,” SMST-2000 Conference Proceedings, 2001, pp. 531-541. |
SMST-2000, “Proceedings of the International Conference on Shape Memory and Superelastic Technologies,” Apr. 30, to May 4, 2000, Asilomar Conference Center. |
Ruiz et al. “the Puncture Technique: A New Method for Transcatheter Closure of Patent Foramen Ovale,” Catheterization and Cardiovascular Interventions 53, Wiley-Liss, Inc., 2001, pp. 369-372. |
International Search Report, International Application No. PCT/US03/17390, mailed on Oct. 6, 2003, 4 pgs. |
Nat'l Aeronautics and Space Administration, “55-Nitinol—The Alloy with a Memory: Its Physical Metallurgy, Properties, and Applications,” A Report, pp. 24-25. |
Kimura, A., et al., “Effects of Neutron Irradiation on the Transformation Behavior in Ti—Ni Alloys,” Abstract, Proceedings of the Int'l Conf. On Mariensitic Transformations (1992) pp. 935-940. |
Ramanathan, G., et al., “Experimental and Computational Methods for Shape Memory Alloys,” 15th ASCE Engineering Mechanics Conf., Jun. 2-5, 2003. |
Shabalovskaya, S., “Surface, corrosion and biocompatibility aspects of Nitinol as an implant material,” Bio-Medical materials and Engineering, (2002) vol. 12, pp. 69-109. |
Uchil, J. “Shape Memory Alloys—Characterization Techniques,” Pramana—Journal of Physics, (2002) vol. 58, Nos. 5 & 6, pp. 1131-1139. |
Athanasion, T., “Coronary Artery Bypass with the Use of a Magnetic Distal Anastomotic Device: Surgical Technique and Preliminary Experience,” The Heart Surgery Forum #2004-1024, 2004, 4 pgs. |
Bachthaler, M. et al., “Corrosion of Tungsten Coils After Peripheral Vascular Embolization Theraphy: Influence on Outcome and Tungsten Load”, Catherization and Cardiovascular Interventions, vol. 62, pp. 380-384, 2004. |
European Examination Report, European Application No. 04781644.2, mailed Aug. 23, 2007 (3 pages). |
Falk, V., “Facilitated Endoscopic Beating Heart Coronary Artery Bypass Grafting Using a Magentic Coupling Device,” Journal of Thoracic and Cardiovascular Surgery, vol. 126,(5), pp. 1575-1579. |
Filsoufi, F., et al., “Automated Distal Coronary Bypass with a Novel Magnetic Coupler (MVP system),” J. Thoracic and Cardiovascular Surgery, vol. 127(1), pp. 185-192. |
International Search Report, International Application No. PCT/US02/40850 mailed Jun. 19, 2003 (4 pgs). |
International Search Report, International Application No. PCT/US03/01050, mailed Jul. 8, 2003 (1 pg). |
International Search Report, International Application No. PCT/US03/09051, mailed Sep. 29, 2003 (2 pgs). |
International Search Report, International Application No. PCT/US03/17715, mailed Mar. 24, 2004 (2 pgs). |
International Search Report, International Application No. PCT/US03/32133, mailed Apr. 22, 2004 (1 pg). |
International Search Report, International Application No. PCT/US03/34003 mailed Oct. 3, 2004 (4 pgs). |
International Search Report, International Application No. PCT/US03/35479, mailed Apr. 14, 2004 (2 pgs). |
International Search Report, International Application No. PCT/US03/35998 mailed Jun. 16, 2004 (4 pgs). |
International Search Report, International Application No. PCT/US03/39253, mailed Apr. 19, 2004 (4 pgs). |
International Search Report, International Application No. PCT/US04/022643, mailed Mar. 31, 2005 (2 pgs). |
International Search Report, International Application No. PCT/USO4/026998, mailed Apr. 22, 2005 (5 pgs). |
International Search Report, International Application No. PCT/USO4/029978, mailed Jan. 26, 2005 (3 pgs). |
International Search Report, International Application No. PCT/US05/006703, mailed Jul. 25, 2005 (3 pgs). |
International Search Report, International Application No. PCT/US05/013705 mailed Aug. 4, 2005 (4 pgs). |
International Search Report, International Application No. PCT/US05/015382, mailed Oct. 6, 2005 (4 pgs). |
International Search Report, International Application No. PCT/US06/009978, mailed Jul. 13, 2006 (2 pgs). |
International Search Report, International Application No. PCT/US2007/065526, mailed Aug. 8, 2007 (5 pgs). |
International Search Report, International Application No. PCT/US2007/065541, mailed Aug. 7, 2007 (3 pgs). |
International Search Report, International Application No. PCT/US97/14822, mailed Feb. 20, 1998 (2 pgs). |
International Search Report, International Application No. PCT/US97/17927, mailed Feb. 10, 1998 (1 pg). |
Isotalo, T. et al., “Biocompatibility Testing of a New Bioabsorbable X-Ray Positive SR-PLA 96/4 Urethral Stent”, The Journal of Urology, vol. 163, pp. 1764-1767, Nov. 1999. |
Klima, U., “Magnetic Vascular Port in Minimally Invasive Direct Coronary Artery Bypass Grafting,” Circulation, 2004, II-55-II-60. |
Meier, MD, Bernhard et al., “Contemporary Management of Patent Foramen Ovale,” American Heart Association, Inc., Circulation, 2003, vol. 107, pp. 5-9. |
Parviainen, M. et al., “A New Biodegradable Stent for the Pancreaticojejunal Anastomosis After Pancreaticoduodenal Resection: In Vitro Examination and Pilot Experiences in Humans”, Pancreas, vol. 21, No. 1, pp. 14-21, 2000. |
Ruddy, A.C. et al., “Rheological, Mechanical and Thermal Behaviour of Radipaque Filled Polymers”, Polymer Processing Research Centre, School of Chemical Engineering, Queen's University of Belfast, 5 pages. |
Vaajanen, A. et al., “Expansion and Fixation Properties of a New Braided Biodegradable Urethral Stent: An Experimental Study in the Rabbit”, The Journal of Urology, vol. 169, pp. 1771-1174, Mar. 2003. |
European Examination Report, European Application No. 03779297.5, mailed arch 15, 2007 (6 Pages). |
International Search Report for International Patent Application No. PCT/AU03/00759, filed Jun. 19, 2003. |
International Search Report, International Application No. PCT/US05/34276, mailed Oct. 9, 2007. |
International Search Report, International Application No. PCT/US07/065546, mailed Oct. 29, 2007. 4 pages. |
European Search Report, European Application No. 03729663.9, mailed Feb. 20, 2008 (3 Pages). |
European Search Report, European Application No. 03716812.7, mailed Mar. 14, 2008 (3 Pages). |
International Search Report, International Application No. PCT/US07/065546, mailed Oct. 29, 2007 (4 pages). |
Number | Date | Country | |
---|---|---|---|
20030225421 A1 | Dec 2003 | US |
Number | Date | Country | |
---|---|---|---|
60366534 | Mar 2002 | US |